(Q27853341)

English

Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy.

scientific article

In more languages

Statements

scholarly article

2 references

13 November 2016

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Johanna M Tuomela

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Lan Yu

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Miikka Tuomala

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Heikki Seikkula

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Teresa Elo

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Markku Kallajoki

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Pekka Taimen

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Peter J Boström

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Kalle Alanen

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Martti Nurmi

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Matthias Nees

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Pirkko Härkönen

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

0 references

publication date

12 March 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

International Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

139

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

140-152

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

The role of fibroblast growth factors and their receptors in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

FGF-8 is involved in bone metastasis of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Fibroblast growth factor homologous factor 2 (FHF2): gene structure, expression and mapping to the Börjeson-Forssman-Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS-like patient

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Fibroblast growth factor homologous factors are intracellular signaling proteins

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Fibroblast growth factor 13 is a microtubule-stabilizing protein regulating neuronal polarization and migration

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Fibroblast growth factor homologous factor 2B: association with Nav1.6 and selective colocalization at nodes of Ranvier of dorsal root axons

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Fibroblast growth factor homologous factors and the islet brain-2 scaffold protein regulate activation of a stress-activated protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Upregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Integrative genomic profiling of human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

An update of the Gleason grading system

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Establishment and characterization of a prostatic small-cell carcinoma cell line (PSK-1) derived from a patient with Klinefelter syndrome

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Isoform diversity among fibroblast growth factor homologous factors is generated by alternative promoter usage and differential splicing

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Paths of FGFR-driven tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Fibroblast growth factor signaling in tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Murine FGF-12 and FGF-13: expression in embryonic nervous system, connective tissue and heart.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Crystal Structure of a Fibroblast Growth Factor Homologous Factor (FHF) Defines a Conserved Surface on FHFs for Binding and Modulation of Voltage-gated Sodium Channels

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Identification of novel interaction sites that determine specificity between fibroblast growth factor homologous factors and voltage-gated sodium channels

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Dual roles of voltage-gated sodium channels in development and cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Voltage-gated Na+ channels confer invasive properties on human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Differential expression of voltage-activated Na+ currents in two prostatic tumour cell lines: contribution to invasiveness in vitro

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Contribution of functional voltage‐gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. lateral motility

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Expression of Voltage-Gated Sodium Channel Nav1.8 in Human Prostate Cancer is Associated with High Histological Grade

1 reference

https://api.crossref.org/works/10.1002%2FIJC.30048

21 January 2018

Identifiers

10.1002/IJC.30048

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

2 references

13 November 2016

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26891277%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27853341&oldid=1616496937"